Senile Cataract Clinical Trial
Official title:
Subclinical Sympathetic Response Related to Second-eye Pain in Cataract Surgery and Its Noninvasive Detection Index
Verified date | November 2018 |
Source | Shanghai Eye Disease Prevention and Treatment Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The degree of perceived pain in the second-eye surgery of cataract patients is significantly
higher than that in the first-eye surgery, which can lead to nervous tension during surgery
and affect the surgical outcome and satisfaction. Study suggested that in addition to
psychological factors, there might be subclinical sympathetic reactions leading to increased
pain in the second-eyes, but the objective indicators and clinical relevance are not clear.
Therefore, it is necessary to study the mechanism of second-eye pain in cataract surgery, and
to provide a test index that can effectively predict the degree of intraoperative pain in
patients, as an important reference for the development of a suitable time for second eye
surgery.
This study is based on clinical case studies, recruiting patients with clinically diagnosed
binocular age-related cataract and require binocular surgery, to compare the correlation of
intraocular inflammatory factors in the second eye and patients' self-pain scores while both
eyes' surgery are completed by the same doctor in the same operating room, and the
correlation of the change of inflammatory factors and the time interval between the two eyes
surgery, to analyze the second-eye subclinical sympathetic reaction changing with the time
interval after the first cataract surgery from the molecular biological results. Using the
latest international anterior segment vascularization optical coherence tomography(OCT) scan
and optical microvascular imaging(OMAG) analysis technology to quantify iris blood flow, this
study analyzes the iris blood flow density, vascular density and other indicators before and
after cataract surgery, and carry out its correlation with the degree of intraocular
subclinical sympathetic reaction, providing a rapid, non-invasive objective examination index
of the second-eye subclinical sympathetic response.
Status | Not yet recruiting |
Enrollment | 600 |
Est. completion date | October 30, 2021 |
Est. primary completion date | August 30, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 40 Years to 80 Years |
Eligibility |
Inclusion Criteria: 1. diagnosed with binocular age-related cataract. 2. Both eyes require phacoemulsification and intraocular lens implantation. 3. binocular surgery was performed by the same physician in the same operating room, and the anesthesia and surgical procedures were consistent. 4. Patients can fully understand the research purpose, research content, accidents and benefits and risks of the clinical trial, and can make their own decisions on participating or not. Exclusion Criteria: |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Shanghai Eye Disease Prevention and Treatment Center | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Surgery Pain Severity Score | visual analogue scale is used to assess the surgery pain. Visual analogue scales (VAS) are psychometric measuring instruments designed to document the characteristics of disease-related symptom severity in individual patients. A VAS is usually a 100-mm long horizontal line with verbal descriptors (word anchors) at each end to express the extremes of the feeling, the position of the respondent's cross is generally assigned a score between 0 and 100. | Within one hour after first eye surgery; within one hour after second eye surgery (performed up to 90 days after first eye surgery) | |
Secondary | Change in Concentration of inflammatory factors in aqueous humor | the Concentrations of tumor necrosis factor-a,interleukin-1,interleukin-6,interleukin-8,monocyte chemotactic protein-1,interleukin2,macrophage inflammatory protein-1a,macrophage inflammatory protein-1,carbon tetrachloride ,chemokine ligand 9,Tissue inhibitor of matrix metalloproteinase 01,C-C motif chemokine 11 are measured using Luminex | aqueous humor is acquired at the beginning of the first eye surgery and the second eye surgery (performed up to 90 days after first eye surgery) | |
Secondary | Change in blood flow density of iris vascular | CIRRUS High Definition-OCT 5000(Carl Zeiss Meditec, Dublin, CA) | Within 24 hours before first eye surgery and Day 1, Week 1, Week 3, Month 1, Month 3 after first eye surgery, or within 24 hours before second-eye surgery (performed up to 90 days after first eye surgery) | |
Secondary | Change in vascular density of iris vascular | CIRRUS High Definition-OCT 5000(Carl Zeiss Meditec, Dublin, CA) | Within 24 hours before first eye surgery and Day 1, Week 1, Week 3, Month 1, Month 3 after first eye surgery, or within 24 hours before second-eye surgery (performed up to 90 days after first eye surgery) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04468308 -
VRQOL in Cataract Patients During the COVID-19 Pandemic
|
||
Completed |
NCT06192901 -
Safety and Performance of Hydrophobic and Hydrophilic Intraocular Lenses After Bilateral Cataract Surgery
|
||
Completed |
NCT06383754 -
Clareon Intraocular Lens Stability in Vitrectomy Patients: CLOVE Study
|
N/A | |
Completed |
NCT03262285 -
Corneal Endothelial Cell Loss After Phacoemulsification Compared With Extracapsular Cataract Extraction
|
||
Recruiting |
NCT05646004 -
621 Real World Study
|
N/A | |
Active, not recruiting |
NCT02966496 -
Safety and Efficacy of Implantation of Two Multifocal Intraocular Lenses in the Treatment of Senile Cataract
|
N/A | |
Completed |
NCT03050008 -
Efficacy of FLACS USFREE Compared to Traditional Surgery Using Ultrasound.
|
N/A | |
Completed |
NCT04972435 -
Effect of Multifocal Intraocular Lens on Contrast Sensitivity in Primary Angle-Closure Patients
|
N/A | |
Completed |
NCT05014269 -
Phacoemulsification in Patients With Corneal Opacities
|